Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma. | Aging (Albany NY) | 2020 | 33323552 | PubTator, text mining | PubMed |
| Emergence of Nanotechnology to Fight HIV Sexual Transmission: The Trip of G2-S16 Polyanionic Carbosilane Dendrimer to Possible Pre-Clinical Trials. | Int J Mol Sci | 2020 | 33321835 | PubTator, text mining | PubMed |
| Convergent network effects along the axis of gene expression during prostate cancer progression. | Genome Biol | 2020 | 33317623 | PubTator, text mining | PubMed |
| Hepatic transcriptome and DNA methylation patterns following perinatal and chronic BPS exposure in male mice. | BMC Genomics | 2020 | 33297965 | PubTator, text mining | PubMed |
| Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management. | Clin Proteomics | 2020 | 33292167 | PubTator, text mining | PubMed |
| External quality assessment program for biochemical assays of human seminal plasma: a French 6-years experience. | Basic Clin Androl | 2020 | 33292159 | PubTator, text mining | PubMed |
| Antibody-drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management. | Indian J Pharmacol | 2020 | 33283772 | PubTator, text mining | PubMed |
| Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study. | JCO Precis Oncol | 2020 | 33283137 | PubTator, text mining | PubMed |
| Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy. | J Immunol Res | 2020 | 33282961 | PubTator, text mining | PubMed |
| Complex genetic dependencies among growth and neurological phenotypes in healthy children: Towards deciphering developmental mechanisms. | PLoS One | 2020 | 33270668 | PubTator, text mining | PubMed |
| SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery. | J Immunother Cancer | 2020 | 33268350 | PubTator, text mining | PubMed |
| Prognostic Value of 18F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223. | Biomedicines | 2020 | 33266047 | PubTator, text mining | PubMed |
| Cancer Prevention by Natural Products Introduced into the Diet-Selected Cyclitols. | Int J Mol Sci | 2020 | 33256104 | PubTator, text mining | PubMed |
| Dexosomes as a cell-free vaccine for cancer immunotherapy. | J Exp Clin Cancer Res | 2020 | 33228747 | PubTator, text mining | PubMed |
| A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs). | Cancers (Basel) | 2020 | 33212880 | PubTator, text mining | PubMed |
| Urinary glycoproteins associated with aggressive prostate cancer. | Theranostics | 2020 | 33204318 | PubTator, text mining | PubMed |
| Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19. | Evid Based Complement Alternat Med | 2020 | 33204291 | PubTator, text mining | PubMed |
| The Vehicle Determines the Destination: The Significance of Seminal Plasma Factors for Male Fertility. | Int J Mol Sci | 2020 | 33198061 | PubTator, text mining | PubMed |
| Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis. | Front Genet | 2020 | 33193613 | PubTator, text mining | PubMed |
| Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. | Cells | 2020 | 33167477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=34